DCA administered with TNF-related apoptosis-inducing ligand (TRAIL) nanoliposomes synergistically increased apoptosis in lung adenocarcinoma, colorectal, and breast cancer cells. This evidence concerns the gene TNFSF10 and breast carcinoma.